Effective as of August 2, 2021, Neil Abdollahian resigned from his position as the Chief Business Officer of Cidara Therapeutics, Inc. Mr. Abdollahian resigned from the Company in order to pursue other opportunities. Mr. Abdollahian has agreed to serve as a consultant to the Company following his resignation until December 31, 2021 to assist with the transition of his duties, and his outstanding Company equity awards will continue to vest during such period of transition services.